- Home
- RGNX vs BGH Comparison
RGNX vs BGH Comparison
Compare RGNX & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- BGH
- Stock Information
- Founded
- RGNX 2008
- BGH 2012
- Country
- RGNX United States
- BGH United States
- Employees
- RGNX N/A
- BGH N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- BGH Investment Managers
- Sector
- RGNX Health Care
- BGH Finance
- Exchange
- RGNX Nasdaq
- BGH Nasdaq
- Market Cap
- RGNX 387.0M
- BGH 318.8M
- IPO Year
- RGNX 2015
- BGH N/A
- Fundamental
- Price
- RGNX $8.18
- BGH $14.77
- Analyst Decision
- RGNX Strong Buy
- BGH
- Analyst Count
- RGNX 8
- BGH 0
- Target Price
- RGNX $31.75
- BGH N/A
- AVG Volume (30 Days)
- RGNX 1.2M
- BGH 61.5K
- Earning Date
- RGNX 05-12-2025
- BGH 01-01-0001
- Dividend Yield
- RGNX N/A
- BGH 10.06%
- EPS Growth
- RGNX N/A
- BGH N/A
- EPS
- RGNX N/A
- BGH N/A
- Revenue
- RGNX $156,718,000.00
- BGH N/A
- Revenue This Year
- RGNX $285.14
- BGH N/A
- Revenue Next Year
- RGNX N/A
- BGH N/A
- P/E Ratio
- RGNX N/A
- BGH N/A
- Revenue Growth
- RGNX 80.70
- BGH N/A
- 52 Week Low
- RGNX $5.04
- BGH $11.92
- 52 Week High
- RGNX $17.52
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- RGNX 51.88
- BGH 62.29
- Support Level
- RGNX $6.89
- BGH $14.34
- Resistance Level
- RGNX $10.59
- BGH $14.51
- Average True Range (ATR)
- RGNX 0.76
- BGH 0.16
- MACD
- RGNX -0.16
- BGH 0.10
- Stochastic Oscillator
- RGNX 34.86
- BGH 94.86
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.